Sales of Amylyx's ALS drug, Relyvrio, beat fourth-quarter expectations on Thursday, and AMLX stock bounded well above its 50-day line.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles
Home » Amylyx Stock Rockets As ALS Drug Tacks On Another Triple-Digit Quarter